{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:19:11Z","timestamp":1793117951814,"version":"4.5.0"},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T00:00:00Z","timestamp":1269475200000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>Pavuluri MN, Passarotti AM, Mohammed T, Carbray JA, Sweeney JA. Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder.\u2028Bipolar Disord 2010: 12: 213\u2013220. \u00a9 2010 The Authors.\u2028Journal compilation \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Objective:\u2002<\/jats:bold> To examine the treatment impact of lamotrigine on the neurocognitive profile of patients with pediatric bipolar disorder (PBD).<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> Healthy controls (HC) (n\u2003=\u200324; mean age\u2003=\u200312.4\u2003\u00b1 3.3\u2003years) and unmedicated PBD patients with manic, mixed, or hypomanic episodes (n\u2003=\u200334; mean age\u2003=\u200313\u2003\u00b1\u20033.1\u2003years) were matched for IQ, age, sex, race, and socioeconomic status. A neurocognitive battery was administered at baseline and again after 14\u2003weeks, during which PBD patients were treated with lamotrigine.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Clinical symptoms improved with treatment in the patient group with significant change from baseline to follow\u2010up on the Young Mania Rating Scale (p\u2003&lt;\u20030.001) and the Children\u2019s Depression Rating Scale\u2013Revised (p\u2003&lt;\u20030.001). Global neurocognitive function improved with lamotrigine in PBD patients over time relative to that in HC, although overall performance remained impaired. Working memory and verbal memory significantly improved with treatment in patients, and deficits in these domains were no longer significantly impaired relative to HC at follow\u2010up. Executive function significantly improved with treatment in the patient group but still lagged behind HC at follow\u2010up. Performance on attention tests did not improve with treatment.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> There appears to be significant improvement in cognitive abilities in PBD patients treated with lamotrigine that is most prominent in the areas of working memory and verbal memory and that occurs along with mood stabilization.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2010.00792.x","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T11:55:24Z","timestamp":1269518124000},"page":"213-220","source":"Crossref","is-referenced-by-count":46,"title":["Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder"],"prefix":"10.1111","volume":"12","author":[{"given":"Mani N","family":"Pavuluri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra M","family":"Passarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahseen","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Carbray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,25]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000242240.69678.c4"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000189135.05060.8a"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0954579406060597"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.03.027"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.286"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.9.1177"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00508.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.2.321"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.29201.x"},{"issue":"7","key":"e_1_2_8_11_2","first-page":"255","article-title":"Tolerability of lamotrigine and carbamazepine in healthy senior adults","volume":"41","author":"Sinclair K","year":"2000","journal-title":"Epilepsia"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000204332.64390.f3"},{"key":"e_1_2_8_13_2","first-page":"46","article-title":"Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium","volume":"8","author":"Gualtieri CT","year":"2006","journal-title":"MedGenMed"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000216273.94142.84"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1107"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3180a76dd2"},{"key":"e_1_2_8_17_2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders IV, 4 ed","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00176-1"},{"key":"e_1_2_8_20_2","volume-title":"Trail Making Test: Manual for Administration and Scoring","author":"Reitan RM","year":"1986"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00278-0"},{"key":"e_1_2_8_22_2","volume-title":"Standardisation and Cross\u2010Validation Study of Cogtest, an Automated Neurocognitive Battery for Use in Clinical Trials","author":"Sharma T","year":"2002"},{"key":"e_1_2_8_23_2","volume-title":"Weschler Adult Intelligence Scale\u2010Revised; Manual","author":"Weschler D","year":"1987"},{"key":"e_1_2_8_24_2","volume-title":"Wechsler Memory Scale \u2013 3rd Edition (WMS\u2010III)","author":"Wechsler D","year":"1997"},{"key":"e_1_2_8_25_2","volume-title":"California Verbal Learning Test\u2010Children\u2019s Version (CVLT\u2010C) Manual","author":"Delis DC","year":"1994"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198403000-00011"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1986.tb03573.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199611)24:3<248::AID-SYN7>3.0.CO;2-E"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00373920"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2007.05.009"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e318196b907"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.07.019"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.75.2.210"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(03)00701-7"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e31802d0b3d"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.9.1644"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.3.246"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.180.4.293"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00910-0"},{"key":"e_1_2_8_40_2","unstructured":"PavuluriM O\u2019ConnorMM HarralE SweeneyJA.Neurocognitive outcome of lamotrigine in pediatric bipolar disorder. Poster presented at the 45th Annual Meeting of the American College of Psychopharmacology December 3\u20137 2006 Hollywood FL USA."}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2010.00792.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2010.00792.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:09:25Z","timestamp":1698746965000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2010.00792.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1399-5618.2010.00792.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2010.00792.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}